Adcock, Katherine S.
Danaphongse, Tanya
Jacob, Sarah
Rallapalli, Harshini
Torres, Miranda
Haider, Zainab
Seyedahmadi, Armin
Morrison, Robert A.
Rennaker, Robert L.
Kilgard, Michael P.
Hays, Seth A.
Funding for this research was provided by:
National Institute of Neurological Disorders and Stroke (R01 NS103803, R01 NS103803, R01 NS094384)
Article History
Received: 22 March 2022
Accepted: 10 May 2022
First Online: 11 June 2022
Competing interests
: MPK is a consultant for and shareholder in MicroTransponder, which is developing VNS for stroke. RLR is CEO of XNerve, which is developing VNS technology. All other authors declare no competing interests.